Keynote talk title: Phosphoproteomics and AI-Driven Drug Prediction for Personalized Cancer Therapy
Yu-Ju Chen obtained her B.S. in Chemistry from National Taiwan University (1992) and Ph.D. degree at Iowa State University. After postdoctoral research work at the Ames Laboratory, Department of Energy, USA and National Tsing Hua University, she joined the Institute of Chemistry of Academia Sinica in 1999, served as the Director (2013-2021) and is currently a Distinguished Research Fellow. She also holds con-current adjunct professorships at few universities. With great passion to reveal disease network, Yu-Ju is one of the pioneering scientists in establishing mass spectrometry-based proteomics in Taiwan. In particular, she is interested in applying these tools for in-depth exploration of the proteome network in biology and diseases. She also contributes to academia services, serving as Associate Editor of “Analytical Chemistry” (since 2020), the most renown journal in analytical science. She has been the President of the Taiwan Proteomics Society (2009-2011), President of Taiwan Society for Mass Spectrometry (2011-2013), Vice President (2017-2019) of AOHUPO. She is the current President of Human Proteome Organization (HUPO, 2021-2022)-largest international society in proteomics, and Vice President (President-elect) of The Chemical Society located in Taipei (2021-2022). She is leading the Taiwan Cancer Moonshot project under the collaboration framework of the International Cancer Proteogenome Consortium (ICPC) led by National Cancer Institute, USA. The first study has revealed the pathogenesis and progression of non-smoking lung cancer patients in Taiwan (Cell, Cover Story). Her technology was also translated into a start-up company for cancer diagnosis (2018, JUN ZHI Biomedical Co., Ltd).
